May is Hepatitis Awareness Month |
For Hepatitis Awareness Month, we are launching a new virtual education series and sharing a new podcast on hepatitis B and HIV, which you can read about below! |
|
Learn more about hepatitis B: a new webinar series |
|
In recognition of Hepatitis Awareness Month, we are presenting a new webinar, "Hepatitis B and HIV Screening, Prevention and Management for African Immigrants and Refugees in the United States: Barriers and Solutions."
Our diverse panel of experts will share insights about the unique challenges faced by this growing community.
This webinar will be held on May 17 at 1 p.m. EDT.
|
|
|
May also is Asian American & Pacific Islander Heritage Month |
|
|
|
During AAPI Heritage Month, we're celebrating some of the amazing people in the hepatitis B community who share that heritage.
Joan M. Block, RN, BSN, not only co-founded the Hepatitis B Foundation, she is an award-winning advocate for people living with hepatitis B.
Just three years ago, Joan and her husband Dr. Tim Block were the first to receive the new Distinguished Advocacy Service Award from the American Association for the Study of Liver Diseases (AASLD).
|
|
You can read Joan's first-person account of the love story behind the Foundation here. |
|
U.S. insurance companies removing coverage
for hepatitis B drugs
|
Our team has learned that some people living with hepatitis B in the U.S. recently have received notifications from their insurance provider that their coverage will no longer pay for the drug Vemlidy. Such negative decisions occur regularly, unfortunately, and in some previous instances the Hepatitis B Foundation and our allies have successfully pressured insurance companies to reverse course.
If you currently have a prescription to take Vemlidy for your hepatitis B but have learned that your insurance may no longer cover the cost of this medication, please contact us at info@hepb.org. As always, we will keep your information confidential and anonymous.
|
|
HepBCommunity.org Research Showcase now underway! |
Submissions for the Second Annual HepBcommunity.org Research Showcase are now being accepted! Hep B researchers in basic, translational, clinical, public health or social science are invited to showcase their research to encourage dialogue between the scientific and affected communities. There are monetary prizes for researchers with the most engaging discussions and for community members who ask the best questions!
|
Forum members will have a chance to ask questions and vote for the top research. Members will have a chance to win a monetary prize for posting the best questions! Research must be posted by June 20 and voting closes July 18. For details on how you can participate, please visit the HepBCommunity now. |
|
The Philadelphia Story (not the old movie, a new blog post) |
|
Hep Delta, globally, a webinar |
|
Please join us for our next hepatitis delta webinar!
This will be a two-part series on June 8 and 15.
|
|
Please Register Today:
-
register for part 1 here
-
register for part 2 here
|
|
Part 1, June 8 at 10 a.m. EDT, will feature a panel discussion about hepatitis delta in the European context, the status of approvals of Hepcludex (bulevirtide) around the continent and how the medication is changing the HDV landscape. We will be joined by panelists from the UK, Spain, Romania, France and Italy.
Part 2, June 15 at 10 a.m. EDT, will explore the epidemiology of hepatitis delta in areas of the world where bulevirtide has not yet been approved, as well as challenges with diagnostics and management of the virus in different contexts. We’ll have panelists in North America, Africa, Asia and Australia. Hope to see you there!
|
|
Updated FAQs: new questions that we hear from
people living with hep B on a regular basis
|
|
The Hep B Foundation Frequently Asked Questions page is a wonderful resource for anyone with questions about hepatitis B. The questions are written based on real consults that we receive regularly.
Some topics include: talking to your partner about your diagnosis, functional cure, liver cancer, clinical trials and more.
|
|
|
Welcoming an experienced communicator to our team |
|
|
|
Monique Benvenutti joined us recently as social media and communications manager.
A former technician at The Hospital of the University of Pennsylvania, Monique transitioned to communications a few years ago. Most recently she was managing the social media, websites and other communications for a school district outside of Philadelphia, not far from our headquarters.
Monique and her husband are raising three children, who are very active in sports, music and school.
|
|
Journal article of the month.
|
|
Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B
Lim Y-S, Kim WR, Dieterich D, Kao J-H, Flaherty JF, Yee LJ,
Roberts LR, Razavi H, Kennedy PTF
2023, 15(4), 997; / Accepted: 14 April 2023 / Published: 18 April 2023
|
|
A new review article by Lim, et al., published in Viruses reviews the data on early antiviral treatment for hepatitis B, including the impact on disease progression, HCC risk, and economics. The accumulated data suggest that starting treatment early for hepatitis B can save many lives and be cost-effective. The authors suggest treatment strategies to simplify treatment and prevent negative health outcomes.
|
|
Join us in the fight against hepatitis B! |
|
|
|
With nearly 300 million people affected worldwide, this virus is a major health threat. The Hepatitis B Foundation is dedicated to finding a cure and improving the lives of those impacted by the virus through research, education and advocacy.
By supporting the Hepatitis B Foundation, you can make a real difference in the lives of millions of people. Your donation will help fund vital research and educational programs to prevent, treat and cure hepatitis B. Together, we can create a world free of hepatitis B.
Join us today and give at
|
|
May: Hepatitis Awareness Month
July 24-26: Hep B United Summit in Washington, D.C.
July 28: World Hepatitis Day
|
|
Learn more about our research and education programs at www.hepb.org
|
|
The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B worldwide. Our commitment includes funding focused research, promoting disease awareness, supporting immunization and treatment initiatives, and serving as the primary source of information for patients and their families, the medical and scientific community, and the general public. |
|
|
|
Hepatitis B Foundation I 3805 Old Easton Road Doylestown, PA 18902 I
215-489-4900 I info@hepb.org
|
|
|
|
|
|
|
